Differential effects of antibiotics on neutrophils exposed to lipoteichoic acid derived from Staphylococcus aureus
- PMID: 33143710
- PMCID: PMC7641855
- DOI: 10.1186/s12941-020-00392-w
Differential effects of antibiotics on neutrophils exposed to lipoteichoic acid derived from Staphylococcus aureus
Abstract
Background: Persistent bacteremia occurs in at least 30% of patients with Staphylococcus aureus bloodstream infection (SAB) and may be attributable to a dysregulated host immune response. Neutrophils interact with a variety of S. aureus microbial factors, including lipoteichoic acid (LTA), to activate phagocytic function in a concentration-dependent manner. Antibiotics have been shown to exert both direct antimicrobial action as well as immunomodulatory effects. In this study, we compared the effects of different anti-staphylococcal antibiotics on LTA-mediated immune activation of neutrophils.
Methods: Neutrophils obtained from healthy volunteers were exposed to two levels of LTA (1 and 10 μg/ml) with or without addition of antibiotics from different pharmacologic classes (vancomycin, daptomycin, ceftaroline). Neutrophil function was assessed by examining phagocytic response, activation (CD11b, CD62L expression), Toll-like receptor-2 expression, cell survival and apoptosis, and CXCL8 release.
Results: Differential LTA-mediated antibiotic effects on neutrophil function were observed primarily at the high LTA exposure level. Ceftaroline in the presence of 10 μg/ml LTA had the most prominent effects on phagocytosis and CD11b and CD62L expression, with trends towards increased neutrophil survival and preservation of CXCL8 release when compared to daptomycin and vancomycin with the latter significantly dampening PMN CXCL8 release.
Conclusions: Select antimicrobial agents, such as ceftaroline, exert immunostimulatory effects on neutrophils exposed to S. aureus LTA, which when confirmed in vivo, could be leveraged for its dual immunomodulatory and antibacterial actions for the treatment of persistent SAB mediated by a dysregulated host response.
Keywords: Antibiotics; Ceftaroline; Immunomodulation; Lipoteichoic acid; Staphylococcus aureus bacteremia.
Conflict of interest statement
Funding was provided, in part, by Forest Laboratories, now Allergan to A.W.B.
Figures






Similar articles
-
Lipoteichoic acid (LTA) from Staphylococcus aureus stimulates human neutrophil cytokine release by a CD14-dependent, Toll-like-receptor-independent mechanism: Autocrine role of tumor necrosis factor-[alpha] in mediating LTA-induced interleukin-8 generation.Crit Care Med. 2006 Mar;34(3):835-41. doi: 10.1097/01.ccm.0000202204.01230.44. Crit Care Med. 2006. PMID: 16521278
-
Assessment of invitrosynergy of daptomycin or vancomycin plus ceftaroline for daptomycin non-susceptible Staphylococcus aureus.Diagn Microbiol Infect Dis. 2020 Nov;98(3):115126. doi: 10.1016/j.diagmicrobio.2020.115126. Epub 2020 Jul 8. Diagn Microbiol Infect Dis. 2020. PMID: 32861155
-
Protective activity of anti-lipoteichoic acid monoclonal antibody in single or combination therapies in methicillin-resistant Staphylococcus aureus-induced murine sepsis models.J Infect Chemother. 2020 May;26(5):520-522. doi: 10.1016/j.jiac.2019.12.018. Epub 2020 Jan 28. J Infect Chemother. 2020. PMID: 32001173
-
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.Infect Dis Clin North Am. 2020 Dec;34(4):849-861. doi: 10.1016/j.idc.2020.04.003. Epub 2020 Sep 30. Infect Dis Clin North Am. 2020. PMID: 33011050 Review.
-
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.Infect Dis Clin North Am. 2016 Jun;30(2):491-507. doi: 10.1016/j.idc.2016.02.009. Infect Dis Clin North Am. 2016. PMID: 27208769 Review.
Cited by
-
The Interplay between Antibiotics and the Host Immune Response in Sepsis: From Basic Mechanisms to Clinical Considerations: A Comprehensive Narrative Review.Antibiotics (Basel). 2024 Apr 28;13(5):406. doi: 10.3390/antibiotics13050406. Antibiotics (Basel). 2024. PMID: 38786135 Free PMC article. Review.
-
Dalbavancin Boosts the Ability of Neutrophils to Fight Methicillin-Resistant Staphylococcus aureus.Int J Mol Sci. 2023 Jan 28;24(3):2541. doi: 10.3390/ijms24032541. Int J Mol Sci. 2023. PMID: 36768864 Free PMC article.
-
Circulating neutrophil anti-pathogen dysfunction in cirrhosis.JHEP Rep. 2023 Aug 1;5(11):100871. doi: 10.1016/j.jhepr.2023.100871. eCollection 2023 Nov. JHEP Rep. 2023. PMID: 37822786 Free PMC article. Review.
-
Repurposing of the Fasciolicide Triclabendazole to Treat Infections Caused by Staphylococcus spp. and Vancomycin-Resistant Enterococci.Microorganisms. 2021 Aug 10;9(8):1697. doi: 10.3390/microorganisms9081697. Microorganisms. 2021. PMID: 34442776 Free PMC article.
-
Mathematical models to study the biology of pathogens and the infectious diseases they cause.iScience. 2022 Mar 15;25(4):104079. doi: 10.1016/j.isci.2022.104079. eCollection 2022 Apr 15. iScience. 2022. PMID: 35359802 Free PMC article. Review.
References
-
- Pérez-Montarelo D, Viedma E, Larrosa N, Gómez-González C, de Gopegui RE, Muñoz-Gallego I, et al. Molecular epidemiology of Staphylococcus aureus bacteremia: association of molecular factors with the source of infection. Front Microbiol. 2018;9:2210. doi: 10.3389/fmicb.2018.02210. - DOI - PMC - PubMed
-
- Minejima E, Bensman J, She RC, Mack WJ, Tuan Tran M, Ny P, et al. A dysregulated balance of proinflammatory and anti-inflammatory host cytokine response early during therapy predicts persistence and mortality in Staphylococcus aureus bacteremia. Crit Care Med. 2016;44(4):671–679. doi: 10.1097/CCM.0000000000001465. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials